Article
Thymidylate synthase polymorphisms and hematological cancer risk: a meta-analysis.
Leukemia & lymphoma - 1 Jul 2012
Weng Yu, Zhang Jun, Tang Xue, Xie Xinyou, Chen Guangdi
Abstract excerpt
Previous studies on the association of Thymidylate synthase (TYMS) polymorphisms with risk of hematological malignancies have produced conflicting results. The purpose of this meta-analysis was to define the effect of TYMS 5'-untranslated enhanced region (TSER) and 3'-untranslated region (TS3'-UTR) polymorphisms on the risk of hematological malignancies. Seventeen articles were identified as eligible in the case...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
